DexCom Inc (NAS:DXCM)
$ 129.71 3.74 (2.97%) Market Cap: 51.58 Bil Enterprise Value: 49.79 Bil PE Ratio: 83.68 PB Ratio: 22.88 GF Score: 89/100

Q1 2019 DexCom Inc Earnings Call Transcript

May 01, 2019 / 08:30PM GMT
Release Date Price: $29.66 (-2.02%)
Operator

Welcome to the DexCom First Quarter 2019 Earnings Release Conference Call. My name is Adrian, and I'll be your operator for today's call. (Operator Instructions) Please note, the conference is being recorded.

I'll now turn the call over to Matt Dolan. Matt Dolan, you may begin.

Matthew Dolan
DexCom, Inc. - VP of Corporate Development

Thank you, operator, and welcome to DexCom's First Quarter 2019 Earnings Call. Our agenda begins with Kevin Sayer, DexCom's Chairman, President and CEO, who will provide a summary of the quarter; followed by a financial review and outlook from Quentin Blackford, our Executive Vice President and CFO; and then a strategic update from Steve Pacelli, our Executive Vice President of Strategy and Corporate Development.

Following our prepared remarks, we will open up the call for your questions. (Operator Instructions) Please note that there are also slides available related to our first quarter performance on the DexCom Investor Relations website on the Events & Presentations page.

With that, let's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot